Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06003686
Other study ID # 20230202
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 5, 2024
Est. completion date October 31, 2026

Study information

Verified date February 2024
Source University of Miami
Contact Patricia Graham, MS
Phone 3052435119
Email pgraham1@med.miami.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to find out if receiving education regarding increased risks of cardiometabolic disease helps subjects understand these risks and how these risks participants' health.


Recruitment information / eligibility

Status Recruiting
Enrollment 250
Est. completion date October 31, 2026
Est. primary completion date October 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: 1. Men and Women with SCI/D aged 18-70 years. 2. Neurologically complete and incomplete American Spinal Injury Association (ASIA) Impairment scale (AIS) A-D spinal cord levels C5 and below. 3. Enrolled no later than 4 months following discharge from initial rehabilitation from SCI. Exclusion Criteria: 1. Pregnancy determined by urine testing in sexually active females. 2. Cognitive impairment that compromises the legitimacy of consent. 3. Grade 3-4 pressure injury at the time of study entry. 4. Prisoners

Study Design


Intervention

Behavioral:
PVA Consumer Guide
Subject's will receive education on the PVA consumer guide 3 times over the course of the study. Each session will be approximately 10-15 minutes and will consist of a general review of the nutrition, exercise, and general healthy living guidelines content included.
WebMD
Subject's will receive education on how to navigate the WebMD site and find information on health, exercise and nutrition 3 times over the course of the study. Each session will be approximately 10-15 minutes and will consist of a general review of the health and wellness content available on the website. At study completion, subjects in this group will be provided with the PVA guide and a brief orientation of the nutrition, exercise, and general healthy living guidelines content included in the guide.

Locations

Country Name City State
United States Baylor Scott & White Institute for Research Dallas Texas
United States University of Miami - Miami Project to Cure Paralysis Miami Florida
United States University of Minnesota Rehabilitation Minneapolis Minnesota
United States McGuire Research Institute Richmond VA Medical Center Richmond Virginia
United States MedStar National Rehabilitation Network Washington District of Columbia

Sponsors (2)

Lead Sponsor Collaborator
University of Miami National Institute on Disability, Independent Living, and Rehabilitation Research

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Effectiveness of education modules as determined in the Knowledge Test Effectiveness as determined by the number of correct answers on the Knowledge Test where the higher number of correct answers indicates increased knowledge of the information provided. baseline, up to 6 months
Secondary Change in Body Weight as determined by kilograms (kg) Body weight will be measured in kilograms baseline, up to 6 months
Secondary Change in Body composition as determined by Dual X-ray Absorptiometry (DXA) Body composition will be measured in grams using DXA baseline, up to 6 months
Secondary Change in Body composition as determined by Dual X-ray Absorptiometry (DXA) in Percentage Body composition will be expressed as a percentage of body fat (BF) using DXA baseline, up to 6 months
Secondary Change in sugar metabolism as determined by Insulin resistance (IR) Sugar metabolism will be determined as IR calculated using the formula (fasting serum glucose*fasting serum insulin/22.5). Lower values indicate a higher degree of insulin sensitivity. Fasting values are obtained from blood samples baseline, up to 6 months
Secondary Change in Quality of Life (QoL) as measured by Quality Index Spinal Cord Injury Version III A composite score will be obtained to assess change in QoL using a six-point Likert scale. Scores for satisfaction section range from "1- very satisfied" to "6-very dissatisfied". On the important section scoring ranges from "1-very important" to "6- very unimportant" baseline, up to 6 months
Secondary Change in Quality of Life (QoL) Using the International Spinal Cord Injury Basic Data Set QoL values will be determined using a scale ranging from 0 (completely dissatisfied) to 10 (completely satisfied). baseline, up to 6 months
Secondary Change in heart disease risk as determined by cholesterol Risk of heart disease will be measured from a blood sample in mg/dL baseline, up to 6 months.
Secondary Change in heart disease risk as determined by blood pressure (BP) BP will be measured in mmHg using an arm cuff baseline, up to 6 months.
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2